We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 1,251

News bytes
  • Shook Hardy & Bacon LLP
  • USA
  • October 30 2014

The U.S. Food and Drug Administration (FDA) makes available Guidance for Industry titled "Circumstances that Constitute Delaying, Denying, Limiting


Digital health law update Vol. 1 Issue 4
  • Jones Day
  • USA
  • August 7 2015

With exponential growth occurring in the availability of telemedicine and other digital health products and services, patent disputes are sure to


State AGs in the news
  • Dickstein Shapiro LLP
  • USA
  • July 24 2014

CWAG held its annual meeting this week in Park City, Utah, which was attended by several members of Dickstein Shapiro's State Attorneys General


Election analysis
  • Arent Fox LLP
  • OECD, USA
  • November 9 2016

This election has produced a stunning result surprising the pundits, pollsters and many Americans. Despite the often


Rights to your genomic information
  • Fish & Richardson PC
  • USA
  • November 11 2014

What rights do you have to your genomic information? In a recent panel discussion of this topic, and perhaps not surprisingly, the answer of the


Federal Circuit Limits the Safe Harbor Provision and the Scope of 271(g)
  • McDermott Will & Emery
  • USA
  • December 23 2015

Addressing issues of infringement under 35 U.S.C. 271(g) and the safe harbor provision of 271(e), the U.S. Court of Appeals for the Federal


Regulatory Developments Life Sciences Companies Should Expect in the New Presidential Administration
  • Jones Day
  • USA
  • January 20 2017

2017 and beyond promises to be a time for continued evolution and uncertainty for life sciences companies doing business in the United States. In


The convergence of life sciences and high tech: implications for engaging the unengaged
  • Morrison & Foerster LLP
  • USA
  • January 2 2015

Over the past decade, the life sciences have evolved dramatically by integrating technologies from a variety of other scientific disciplines. The


Copyright for Engineered DNA (Part 2)
  • GQ Life Sciences
  • USA
  • March 1 2016

With the United States Supreme Court ruling in Myriad, the enforceability of certain claims in existing gene patents and the broader patentability of


ClearCorrect: ITC and Patentee Align Submit Petitions for Rehearing En Banc, Asking Federal Circuit to Reconsider Whether the ITC Has Jurisdiction Over Digital Imports
  • Mintz Levin Cohn Ferris Glovsky and Popeo PC
  • USA
  • January 29 2016

On January 27, 2016, the International Trade Commission (ITC) formally requested a rehearing en banc of a November 10, 2015, Federal Circuit panel